In a previous post I shared this paper: The declarations of interest were given as follows: I have written the following open letter to the lead author: Sent: 22 May … Continue reading “uncritical partisan narrative”
This perspective has just been published in the Journal of Psychopharmacology. My brief response to one of the authors can be read here, alongside further details of the competing interests of … Continue reading “Antidepressants, withdrawal and addiction: where are we now?”
The authors of this recently published perspective on antidepressants ask: “What’s the beef?” Here is my response: This is an extremely poorly written perspective: the language is clumsy and the … Continue reading “What’s the beef?”
The January 2019 edition of the British Journal of Psychiatry has, as its theme: Treatment-Resistant Mood Disorders. In the Journal a “consensus definition” of “treatment resistance” was provided by a … Continue reading “A wrong un’ when you see it”
I wrote “Transparency at the Top: British Psychiatry” in April 2015 but did not share it publicly as I wanted to give the Royal College of Psychiatrists time to improve … Continue reading Transparency at the Top
Seven years ago this Editorial was published in the BMJ: Eleven years ago, all NHS Chief Executives in Scotland were asked to implement and govern this Scottish Government circular: HDL 62. This … Continue reading “All in the past”: well, no.